Morningstar Investor users sign in here.

Company Profile

  • Business description

    Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

  • Contact

    Grenzacherstrasse 124
    Basel 4070
    CHE

    T: +41 616881111

    E: investor.relations@roche.com

    https://www.roche.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2024

    Employees

    103,605

Roche Holding AG News & Analysis

stocks

Magnificent Seven vs. the ‘Granolas’: How does Europe’s version stack up?

‘Granolas’ stocks are profitable, diversified, cheap—and posting big returns.

Markets

Index
Last price
Change
% Change
All Ordinaries 7,895.90 39.80 -0.50%
CAC 40 7,950.76 15.73 0.20%
DAX 40 18,468.09 5.20 -0.03%
Dow JONES (US) 38,441.54 411.32 -1.06%
FTSE 100 8,211.94 28.87 0.35%
HKSE 18,230.19 246.82 -1.34%
NASDAQ 16,920.58 99.30 -0.58%
Nikkei 225 38,054.13 502.74 -1.30%
NZX 50 Index 11,557.21 121.47 -1.04%
S&P 500 5,266.95 39.09 -0.74%
S&P/ASX 200 7,628.20 37.40 -0.49%
SSE Composite Index 3,091.68 19.34 -0.62%

Market Movers

Name
Last price
Change
% Change
Dalrymple Bay Infrastructure Ltd DBI 2.76 0.07 -2.47%
Telstra Group Ltd TLS 3.44 0.00 0.00%
Pilbara Minerals Ltd PLS 3.80 0.08 -2.06%
Sayona Mining Ltd SYA 0.04 0.00 -4.65%
South32 Ltd S32 3.94 0.01 -0.25%
Peninsula Energy Ltd PEN 0.12 0.01 4.35%
Alumina Ltd AWC 1.82 0.02 0.83%
Imugene Ltd IMU 0.07 0.00 -1.47%
Latin Resources Ltd LRS 0.25 0.00 0.00%
BrainChip Holdings Ltd BRN 0.25 0.01 -2.00%